Analyst Price Targets — AMTX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 12, 2026 2:15 pm | — | Loop Capital Markets | $1.75 | $1.72 | StreetInsider | Texas Capital Securities Reiterates Hold Rating on Aemetis (AMTX): "We view this release as positive" |
| July 30, 2024 3:27 pm | Jirdan Levy | Truist Financial | $3.50 | $3.42 | StreetInsider | Aemetis (AMTX) PT Lowered to $3.50 at Truist Securities |
| May 13, 2024 7:27 am | Jordan Levy | Truist Financial | $4.00 | $4.06 | StreetInsider | Aemetis (AMTX) PT Raised to $4 at Truist Securities |
| February 1, 2023 7:47 am | — | Truist Financial | $5.00 | $4.67 | Benzinga | Truist Securities Maintains Hold on Aemetis, Lowers Price Target to $5 |
| December 14, 2022 4:49 am | — | UBS | $4.25 | $4.43 | Benzinga | UBS Initiates Coverage On Aemetis with Neutral Rating, Announces Price Target of $4.25 |
| August 8, 2022 9:27 pm | Jordan Levy | Truist Financial | $12.00 | $11.12 | TheFly | Aemetis downgraded to Hold from Buy at Truist |
Latest News for AMTX
CUPERTINO, Calif., September 2, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aemetis, Inc. (NASDAQ: AMTX), a diversified renewable natural gas and biofuels company, praised the unanimous passage of California Senate Bill 795, which will allow the state's fuel retailers to utilize existing vapor recovery equipment to dispense E15 based on manufacturer certifications.
Dallas, Texas--(Newsfile Corp. - August 10, 2026) - Aemetis Inc. (NASDAQ: AMTX): Stonegate Capital Partners Updates Coverage on Aemetis Inc. (NASDAQ: AMTX). Aemetis' 2Q26 results made the operating inflection visible, as quarterly 45Z recognition, higher RNG production, and improved ethanol economics drove positive operating income and adj.
Aemetis, Inc. (AMTX) Q2 2026 Earnings Call Transcript
Aemetis NASDAQ: AMTX reported higher second-quarter revenue and a return to operating profitability, citing growth in its California ethanol and dairy renewable natural gas businesses as well as contributions from federal Section 45Z production tax credits.
Aemetis (AMTX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.41 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AMTX.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.